EHang Holdings Ltd - ADR vs Revvity Inc — how do they compare? EHang Holdings Ltd - ADR trades at $5.44 (market cap $414.87M), while Revvity Inc trades at $111.22 (market cap $12.42B). The key difference: Revvity Inc is far larger — about 29.9× EHang Holdings Ltd - ADR's market cap, and Revvity Inc pays a 0.25% dividend while EHang Holdings Ltd - ADR pays none. Which is the better fit depends on your goals.
| EH | RVTY | |
|---|---|---|
Market Cap | $414.87M | $12.42B |
Sector | Industrials | Technology |
52-Week High | $19.99 | $117.75 |
52-Week Low | $5.41 | $82.26 |
Enterprise Value | $354.54M | $14.91B |
Dividend Yield | — | 0.25% |
Signals from Pluang's Aura AI — not financial advice
EHang Holdings (EH) trades at $5.56, up 2.02% on the day, amid mixed technical and fundamental signals. The stock shows a bearish technical trend with oversold short-term RSI, while fundamentally, the company reported Q1 2026 revenue of $418M, flat year-over-year but sharply lower sequentially due to delivery timing. The company remains unprofitable with a net margin of -77.56% and negative ROE of -34.03%, though it maintains a strong cash position of $1.12B and recently announced a $30M share repurchase program.
The outlook is bifurcated between significant long-term potential in the advanced air mobility market and near-term execution and profitability challenges. Investment opportunity lies in the company's first-mover technology and global regulatory progress, but risks include persistent cash burn, high valuation multiples despite losses, and intense competition in the emerging eVTOL sector. Analyst consensus is divided with a $6.97 price target but equal buy/hold/sell ratings.
RVTY trades at $110.99, down slightly by 0.2% today, near the analyst consensus price target of $111.43. The stock shows a bullish technical trend with recent earnings beats in Q3 2025, Q4 2025, and Q1 2026. Strong profitability metrics include a gross margin of 54.32% and net income margin of 8.26%. Recent news highlights AI integration advancements and FDA clearances, supporting growth prospects.
The outlook is positive with analyst consensus leaning buy (51.72%) and no sell ratings. Key risks include margin pressure and macroeconomic headwinds affecting cash flow, which turned negative in 2025 and 2026. The upcoming Q2 2026 earnings report on August 4, 2026, will be critical for validating current growth trajectory and investor confidence.
Trailing returns across standard periods
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →